Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1 2024 Home Health & Hospice Update

Skip to the end of the Expertise Menu

Q1 2024 Home Health & Hospice Update

Home health and hospice deal volume continued its upward trend into the first quarter of this year, building on the momentum from a strong finish in 2023. The first quarter of 2024 showcased continued non-profit deal activity, a growing interest among providers in joint-venture opportunities, a landmark IPO shaping the market, and a successful private equity exit, all contributing to continued activity and sustained valuations throughout the lower middle market.

Looking ahead to the rest of the year, Provident expects continued transaction activity and competitive valuations for top-tier assets across all sub verticals of post-acute care. However, buyers are closely monitoring the potential impact of 80/20 on Medicaid personal care businesses, along with the effects of the increasing transition from Medicare to Medicare Advantage within skilled home health businesses.

To print and download the full Home Health & Hospice Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/04/Q1-2024-Home-Health-and-Hospice-Newsletter.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]